The Research Article on Evaluation of Anti-Parkinson Activity of Alfalfa (Medicago Sativa) Through the Preclinical Studies in Swiss Albino Mice

The anti-Parkinson's activity of Medicago sativa (Medicago Sativa) ethanolic extract is examinedin this research. Some of the phytochemicals that have been identified thus far includeglycosides, fixed oils, tannins, alkaloids, saponins, and flavonoids. The effects of medicinalginseng on dopamine and catalase enzyme levels suggest that it may be useful in alleviating PD-related behavioral symptoms. One reason for its medicinal benefits is the presence of flavonoidcomponents in the seed extract, namely baicalein and baicalin, which are recognized for theirantioxidant capabilities. After administering Medicago sativa, the study plans to monitor changesin motor function, biochemical markers, and antioxidant status. Results like this should shedlight on the pathogenesis of PD and point the way to potential novel treatments. To furtherunderstand how Medicago sativa exerts its anti-Parkinson effects, more research is required.Clinical translation of treatments based on Medicago sativa for the management of Parkinson'sdisease is supplemented by the results of this research project, which seek for increasepharmacological knowledge.